BN Business News
Add your company to Business Communicator →

Business · 07/06/2023Updated: 10/17/2026 · 1 min read

FDA Revokes Emergency Use Authorization for Propofol-Lipuro 1% Emulsion

Summary

The FDA has revoked the Emergency Use Authorization for Propofol-Lipuro 1% emulsion, a medication used during the COVID-19 pandemic, due to a lack of inventory and the manufacturer's decision not to offer the product in the US.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →